Open AccessActive Vitamin D (1,25-Dihydroxyvitamin D) and Bone Health in Middle-Aged and Elderly Men: The European Male Aging Study (EMAS)
Author(s) -
Dirk Vanderschueren,
Stephen R. Pye,
Terence W O’Neill,
David M. Lee,
Ivo Jans,
Jaak Billen,
Evelien Gielen,
Michaël R. Laurent,
Frank Claessens,
Judith E. Adams,
Kate A. Ward,
György Bártfai,
Felipe F. Casanueva,
Joseph D. Finn,
Gianni Forti,
Aleksander Giwercman,
Thang S. Han,
Ilpo Huhtaniemi,
Krzysztof Kula,
Michael E. J. Lean,
Neil Pendleton,
Margus Punab,
Frederick C. W. Wu,
Steven Boonen
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2772
Subject(s) - medicine , vitamin d and neurology , heel , vitamin d deficiency , bone health , population , bone remodeling , procollagen peptidase , endocrinology , osteoporosis , bone mineral , anatomy , environmental health
There is little information on the potential impact of serum 1,25-dihydroxyvitamin D [1,25(OH)2D] on bone health including turnover.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom